Egypt Probiotics Market Size, Share, Opportunities, And Trends By Type (Lactobacillus, Streptococcus, Bifidobacterium, Spore Formers, Others), By Form (Liquid, Dry), By Application (Functional Food And Beverages, Dietary Supplements, Animal Feed), And By End-User (Human, Animal) - Forecasts From 2024 To 2029

Description

Egypt Probiotics Market Size:

Egypt’s probiotics market is projected to attain a market size of USD 239.624 million by 2030, growing at an 8.34% CAGR from a valuation of USD 107.585 million in 2020.

Probiotics are live and friendly microorganisms, predominantly bacteria, that act for good health. These microorganisms can benefit the human body and may help in treating various conditions, from irritable bowel syndrome and infectious diarrhea to skin problems like eczema. The market for probiotics in Egypt is expected to grow due to increased consumer awareness of the benefits of probiotics, which contributes to the acceptance of these microorganisms as part of the daily diet, thus substantially driving growth during the forecast period. Besides this, there is a rise in Egyptian consumers preferring to shift towards natural remedies and noninvasive treatment options, such as probiotics, for curing digestive problems, obesity, and other health ailments, instead of opting for pharmaceutical interventions. Moreover, according to the NIH 2024 article, probiotics can assist in preventing and treating overweight and obesity. The rise in the prevalence of obesity and overweight in Egypt will also contribute to the demand for probiotics for reducing accumulated fat in the body. According to the data from the World Obesity Observatory, the prevalence of obesity is highest in Egypt among women between the ages of 15 and 49 years, with 30.1 percent overweight and 55.8 percent obese as of 2022. Additionally, probiotics are witnessing rising demand in the country’s animal feed industry, particularly for poultry, ruminants, and aquaculture. Since probiotics are known for promoting digestive health, enhancing immunity, and fueling the expansion of the number of livestock, while also decreasing the requirement for antibiotics, this aligns with the rising trend toward sustainable farming. For instance, in January 2022, Danisco Animal Nutrition, which is a part of IFF's Health & Biosciences, launched two Omni-Bos probiotics in the Middle East. The company is focused on growing in the global ruminant market, with the launch of Omni-Bos P169 and Omni-Bos CB in Egypt and Jordan. These launches targeting ruminant health will reinforce probiotics market growth in the animal feed sector.

Egypt Probiotics Market Overview:

Probiotics are beneficial live microorganisms, often referred to as friendly bacteria, known for their positive impact on health. These microorganisms offer various health benefits and can effectively address a range of conditions, including irritable bowel syndrome, infectious diarrhoea, and skin issues such as eczema. The growing awareness among individuals about the advantages of probiotics has led to increased adoption of these microorganisms in daily routines, playing a significant role in propelling market growth in the anticipated period. The market is gaining momentum due to rising health consciousness and a relatively good nominal per capita income. With a population of over 116.53 million, particularly driven by urban dwellers (approximately 43% of the total population), youth, and older adults (the number of persons aged 60+ is expected to more than double between 2020 and 2050 from 8.4 million to 22 million), the Egyptian probiotics market is exhibiting robust growth potential. Additionally, the gradual shift away from antibiotic growth promoters to natural alternatives, such as probiotics for animal feed, is also boosting market expansion. However, high inflation (33.9% in 2023), currency volatility, and declining consumer confidence are influencing affordability, restricting demand largely to premium and urban segments. Due to the country’s macroeconomic environment, the market for probiotics is expected to be concentrated in urban centers such as Cairo, Alexandria, and Giza. For humans, probiotics are largely positioned as premium health and wellness products to attract the growing health-conscious upper-middle and high-income consumers. As a result, a growth in the adoption of animal probiotics is noted, opening new B2B opportunities for veterinary probiotic suppliers, feed integrators, and agribusinesses. In the Egyptian probiotics market, strategic collaborations and mergers are becoming increasingly prevalent, contributing to the market's growth. A notable example is the exclusive agreement between BioGaia and Minapharm Pharmaceuticals for the exclusive distribution of BioGaia Protectis drops in Egypt. These probiotics will be available under the BioGaia brand. Hence, such agreements are expected to provide significant growth for the probiotics market in Egypt in the projected period. The market has been regionally segmented into Greater Cairo, Alexandria, the Delta Region, Upper Egypt, the Suez Canal Zone, and Others to understand region-specific consumer demand, health trends, and consumption behavior across key areas of Egypt. Greater Cairo and Alexandria are major consumption regions, while the Delta and Suez regions offer strong animal feed potential. Upper Egypt has very low penetration. The market is moderately consolidated, with a few multinational and regional players dominating key segments, especially in human probiotics. Companies such as Danone, Nestle S.A., DSM, Beyti Egypt, DinaFarms, and Juhayna Food Industries are key players operating in the market. The market lacks domestic brand presence, as the region exhibits high import dependency. The animal segment is even more consolidated with the presence of some major global players such as DSM (Opened Animal Nutrition & Health premix and additives manufacturing plant in Sadat City, Egypt in September 2024). The players are expanding their presence in the market, while innovating many probiotics products, such as the launch of Sandoz’s Linex probiotics with Bifidobacterium lactis BB-12, which supports the balance and function of useful intestinal microflora. Another key distinguishing trend in the market is that the Egyptian probiotics market is increasingly witnessing collaborations and partnerships, particularly because global companies are expanding their foothold in Egypt. For instance, BioGaia signed an agreement with Minapharm Pharmaceuticals for the exclusive rights to sell BioGaia Protectis drops in Egypt.

Egypt Probiotics Market Drivers:

• The growing aging population and geriatric needs: Egypt’s aging demographic would lead to increased demand for probiotics. An increase in population aging is expected to give rise to health concerns, promoting the demand for probiotics that can be used practically for the prevention and treatment of these health conditions. According to the data from the United Nations Population Fund (UNFPA), the country is expected to witness an increase in the aging population and is predicted to double in number between 2020 and 2050. The aging population that is more than 60 years old is expected to grow from 8.4 million, which is 8% of the total population in 2020, to 11.47 million in 2030 and further to 22.03 million, i.e., 14 percent of the total population, by 2050. Additionally, aging is linked with multimorbidity related to neurodegenerative and musculoskeletal disorders, cardiovascular, metabolic diseases, and cancer. Such conditions can be improved by probiotics, which assist gut health, an important factor for an older-aged individual's well-being. Probiotics reduce inflammation by lowering malondialdehyde levels in plasma and C-reactive protein and improve cognition, as per an MDPI study. Alzheimer’s patients supplemented with Lactobacillus plantarum experienced an improvement in cognitive performance and increased brain-derived neurotrophic factor (BDNF) levels. Moreover, aging is also associated with weak immune systems, making it easier for infections to occur. Probiotics with Bifidobacterium and Lactobacillus strains nourish immunity and may lower infection risk, which is leading to an increase in their adoption in the elderly population of Egypt for their healthcare. Aging can cause gut microbiota changes, such as a reduction in the beneficial bacterial species and an increase in the proteolytic ones, which potentially cause chronic inflammation, also offering rising potential for demand for probiotics in the country. Thus, considering the therapeutic advantage of probiotics, particularly for improving geriatric health and treating several medical conditions, like irritable bowel syndrome and diarrhea, among the older population, is expected to promote the growth in demand during the forecast period.

Egypt Probiotics Market Segmentation Analysis:

• Egypt's probiotics market for animal feed is projected to grow steadily: Probiotic use and interest in Egypt's animal feed business have increased due to the benefits of probiotics for animal health and performance. Probiotics are beneficial bacteria that are added to animal feed to promote digestive health, strengthen the immune system, and quicken development rates. These microorganisms help to maintain a healthy gut microflora, which improves optimal nutrition absorption and reduces the risk of digestive illnesses. In keeping with global efforts to limit the use of antibiotics in animal agriculture, probiotics can also help lower stress and can be used in place of antibiotics. The Egyptian government declared in 2022 that feed prices rose by 40–45%. Additionally, the price of beef went up by 15 to 20 percent, which decreased per capita consumption. Furthermore, owing to the continued devaluation of the Egyptian pound and the complicated import procedures, prices are predicted to rise further. While Brazilian beef imports are still restricted, the number of Indian water buffalo imports has climbed to 150 thousand MT. Egypt produced 390,000 MT of beef in MY 2023, up 5,000 MT or 1.3% from MY 2022 estimations, according to FAS Cairo. Egypt's domestic beef consumption reached 660,000 in MY 2023, increasing less than 1% from estimates for MY 2022 of 655,000 or 5,000 MT. Egypt's production (calf crop) reached 1.95 million head in the MY 2023, according to FAS Cairo, which is 0.5 percent less than the USDA's official MY 2022. Many farmers, especially those who own small and medium-sized husbandries, chose to either retain or reduce the amount of their production due to the high costs of production, especially feed. Only integrated farms managed to withstand the difficult feed scarcity and exorbitant costs. As a result, the post announced that the Egyptian herd modestly expanded to 1.95 million head, which was marginally less than the USDA's official estimate for MY 2022. According to FAS Cairo, Egypt's imports of live cattle stayed at 200,000 head in MY 2023, unchanged from MY 2022.
• The liquid probiotics segment is experiencing increased demand: Liquid probiotics are largely driven by yoghurt and drinkable formats in Egypt. It holds a key share in Egypt’s probiotics due to the dominance of human-focused probiotics. Among the various formats, functional beverages, such as Danone Greek, GREKO, and Nestle Natural Yoghurt, are experiencing particularly high demand, especially among youngsters and adults, as they are a convenient, daily consumable form that easily integrates into regular diets. Given that digestive and gut health represent the major application segment, consumers increasingly prioritize probiotic functional beverages for their perceived health benefits. This trend is significantly driving the adoption of probiotics in liquid form, as it offers both convenience and health functionality. Major products like SPOGEST?IB Liquid Probiotics, HYLAK Forte, and Zahler Kidophilus Liquid are some liquid-form probiotics. Thus, functional beverages and yoghurts, and liquid dietary supplements are major probiotics that are in liquid form. These products are sold through retail, online e-commerce channels like Amazon, Ubuy, and others, and liquid dietary supplements are easily available at pharmacies, e?commerce sites, and specialized retailers. As urban areas experience growth in health-consciousness, they are driving the demand for liquid probiotics in the form of drinkables, thereby driving the liquid form segment. At the same time, these products are easily accessible through cold-chain retailers, supermarkets, pharmacies, and online platforms. As global probiotics brand are expanding their reach in Egypt, they are increasingly launching new products in functional beverages such as yoghurt drinks or probiotic shots, again driving the liquid segment. In summary, liquid probiotics are a high-share, high-growth segment in the Egyptian market, especially for yoghurts and drinkables. Innovations in cold chain and shelf stability can extend the shelf life and help in rural penetration as well.

Egypt Probiotics Market Key Developments:

• January 2022: a business unit of IFF's Health & Biosciences division, Danisco Animal Nutrition, announced new advancements to its ruminant range. The company introduced two Omni-Bos® probiotics in the Middle East and the BovizymeTM GA enzyme in the United States as part of its continuous efforts to broaden its nutritional health solutions for ruminant producers and broaden its market reach. Danisco Animal Nutrition's successful introduction of Omni-Bos® P169 and Omni-Bos® CB in Egypt and Jordan has reinforced the company's focus on the worldwide ruminant market.

Egypt Probiotics Market Segmentation:

• By Type
  • Lactobacillus
  • Streptococcus
  • Bifidobacterium
  • Spore Formers
  • Others
• By Form
  • Liquid
  • Dry
• By Application
  • Functional Food and Beverages
  • Dietary Supplements
  • Animal Feed
• By End-User
  • Human
  • Animal
• By Region
  • Greater Cairo
  • Alexandria
  • Delta Region
  • Upper Egypt
  • Suez Canal Zone
  • Others

Table Of Contents

Companies Profiled

Danone

Nestlé S.A.

DSM

Beyti Egypt

DinaFarms

Juhayna Food Industries

IFF (International Flavors & Fragrances)

Sandoz Egypt

Multi Vita

Hero Group

BioGia AB

NovoGen Group

Sanofi

Related Reports